Page 323 - Haematologica March 2020

NGS of F7 and minigene studies identify molecular bases of FVII deficiency
Factor VII gene polymorphisms contribute about one third of the factor VII level varia- tion in plasma. Arterioscler Thromb Vasc Biol. 1996;16(1):72-76.
34. Girelli D, Russo C, Ferraresi P, et al. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med. 2000;343(11):774-780.
35. Kudaravalli R, Tidd T, Pinotti M, et al. Polymorphic changes in the 5??? flanking region of Factor VII have a combined effect on promoter strength. Thromb Haemost. 2002;88(5):763-767.
36. Bozzini C, Girelli D, Bernardi F, et al. Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis. Thromb Haemost. 2004;92(3):541-549.
37. Sabater-Lleal M, Chillón M, Howard TE, et al. Functional analysis of the genetic variabil- ity in the F7 gene promoter. Atherosclerosis. 2007;195(2):262-268.
38. Giansily-Blaizot M, Verdier R, Biron- Adréani C, et al. Analysis of biological phe- notypes from 42 patients with inherited fac-
tor VII deficiency: Can biological tests pre- dict the bleeding risk? Haematologica. 2004;89(6):704-709.
39. Giansily-Blaizot M, Thorel D, Khau Van Kien P, et al. Characterisation of a large com- plex intragenic re-arrangement in the FVII gene (F7) avoiding misdiagnosis in inherited factor VII deficiency. Br J Haematol. 2007; 138(3):359-365.
40. Ferrarese M, Testa MF, Balestra D, Bernardi F, Pinotti M, Branchini A. Secretion of wild- type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B. Hum Mutat. 2018;39(5):702– 708.
41. Meyer K, Schümperli D. Antisense Derivatives of U7 Small Nuclear RNA as Modulators of Pre-mRNA Splicing. In: Alternative Pre‐mRNA Splicing. Wiley- Blackwell; 2012:481-494.
42. Pinotti M, Rizzotto L, Balestra D, et al. U1- snRNA-mediated rescue of mRNA process- ing in severe factor VII deficiency. Blood. 2008;111(5):2681-2684.
43. Yeo GW, Van Nostrand EL, Liang TY. Discovery and analysis of evolutionarily conserved intronic splicing regulatory ele-
ments. PLoS Genet. 2007;3(5):e85.
44. Majewski J, Ott J. Distribution and charac- terization of regulatory elements in the human genome. Genome Res. 2002;
12(12):1827-1836.
45. Pinotti M, Toso R, Girelli D, et al.
Modulation of factor VII levels by intron 7 polymorphisms: population and in vitro studies. Blood. 2000;95(11):3423-3428.
46. Dominski Z, Marzluff WF. Formation of the 3’ end of histone mRNA. Gene. 1999; 239(1):1-14.
47. Brun C, Suter D, Pauli C, et al. U7 snRNAs induce correction of mutated dystrophin pre-mRNA by exon skipping. Cell Mol Life Sci. 2003;60(3):557-566.
48. Suter D, Tomasini R, Reber U, Gorman L, Kole R, Schümperli D. Double-target anti- sense U7 snRNAs promote efficient skip- ping of an aberrant exon in three human β- thalassemic mutations. Hum Mol Genet. 1999;8(13):2415-2423.
49. Gorman L, Suter D, Emerick V, Schümperli D, Kole R. Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs. Proc Natl Acad Sci U S A. 1998;95(9):4929-4934.
haematologica | 2020; 105(3)
837